Quantcast

Latest Sulfoxides Stories

2014-10-13 08:26:44

SOUTH SAN FRANCISCO, Calif., Oct. 13, 2014 /PRNewswire/ -- Tobira Therapeutics, Inc., a clinical-stage biopharmaceutical company advancing cenicriviroc (CVC) in liver disease and HIV, announced today that it has dosed the first patient in its CENTAUR study of patients with non-alcoholic steatohepatitis (NASH) and liver fibrosis, a disease affecting approximately 3-5 percent of the U.S. population. The initiation of the CENTAUR study follows the completion of a Phase 1 safety study in...

2014-10-01 12:30:48

SOUTH SAN FRANCISCO, Calif., Oct. 1, 2014 /PRNewswire/ -- Tobira Therapeutics, Inc., a clinical-stage biopharmaceutical company developing cenicriviroc (CVC) in liver disease and HIV, announced today that it will present clinical data showing an improvement in fibrosis scores associated with CVC treatment at the American Association for the Study of Liver Diseases Annual Meeting. The data highlights an analysis of fibrosis scoring measures APRI and FIB-4 in patients from the completed...

2014-08-15 12:22:44

RnRMarketResearch.com adds "Market Research Report on Global and Chinese dimethyl sulfoxide (CAS 67-68-5) Industry, 2009-2019" to its store. DALLAS, Aug. 15, 2014 /PRNewswire-iReach/ -- Market Research Report on Global and Chinese dimethyl sulfoxide Industry, 2009-2019 is a professional and in-depth market survey on Global and Chinese dimethyl sulfoxide industry. The report firstly reviews the basic information of dimethyl sulfoxide including its classification, application and...

2014-08-14 16:27:16

- Creates a diversified, high-growth therapeutic portfolio, capable of delivering substantial, sustainable value for shareholders DUBLIN, Aug. 14, 2014 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced that it has completed its acquisition of Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) in a cash and stock transaction valued at approximately $5.8 billion. The acquisition is expected to be immediately accretive to Mallinckrodt's...

shift work sleep and alertness aids
2014-08-14 03:30:14

The Cochrane Library Shift workers are taking drugs to help them stay awake or get to sleep despite weak evidence for their benefit, according to a new Cochrane review. The authors of the review found only small numbers of trials testing over-the-counter and prescription drugs used by shift workers, and the results suggest that for some people they might do more harm than good. In most developed countries, at least 10% of the workforce is involved in some form of shift work. European...

2014-08-07 12:28:05

BOCA RATON, Fla., Aug. 7, 2014 /PRNewswire/ -- Akron is pleased to announce that it secured a strategic collaboration with Vivex Biomedical, Inc. on the use of its next-generation line of cryopreservation media, CryoNovo(TM). Vivex Biomedical, Inc., from Marietta, GA, designs and develops innovative biologic products for regenerative medicine applications. Tracy Anderson, Vivex CEO, speaks to the imperative, "Vivex underscores its commitment to patient care in the confidence that...

2014-06-30 16:26:43

SOUTH SAN FRANCISCO, June 30, 2014 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical-stage biopharmaceutical company advancing cenicriviroc (CVC) in liver disease and HIV, announced today that it has closed a four year, $15 million term loan facility with Oxford Finance LLC. The facility will support the development of CVC for the treatment of nonalcoholic steatohepatitis (NASH) and for working capital and general corporate needs. About Tobira Therapeutics Tobira Therapeutics is...

2014-05-30 16:25:02

DUBLIN, May 30, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has entered into an agreement with Cephalon, Inc. to settle all outstanding patent litigation related to Actavis' generic version of Nuvigil(® )(armodafinil tablets, 50 mg, 100 mg, 150 mg, 200 mg and 250 mg). Nuvigil(®) is a prescription medicine indicated to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA), shift work disorder (SWD) or...

2014-03-28 12:26:09

DUBLIN, March 28, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/lj5htc/investigation) has announced the addition of the "Investigation Report on China's Esomeprazole Market, 2009-2018" [http://www.researchandmarkets.com/research/lj5htc/investigation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Digestive system disease is one of the most frequently occurring diseases....


Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related